Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma
The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2011 by Dana-Farber Cancer Institute.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
Beth Israel Deaconess Medical Center
Collaborators:
Genentech
Dana-Farber Cancer Institute
Brigham and Women's Hospital
Vanderbilt University
Information provided by:
Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT00782275
First received: October 29, 2008
Last updated: April 13, 2011
Last verified: April 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | December 2011 (Final data collection date for primary outcome measure) |